• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182

Introduction to 3,4-Dimethylcinnamic Acid (CAS No: 60521-25-7)

3,4-Dimethylcinnamic acid, with the chemical formula C₁₀H₁₀O₂, is a derivative of cinnamic acid characterized by the presence of two methyl groups at the 3rd and 4th positions of the phenyl ring. This compound has garnered significant attention in the field of pharmaceutical chemistry and biochemistry due to its versatile biological activities and potential applications in drug development. The systematic name, derived from its structural features, underscores its relationship to cinnamic acid, a well-studied aromatic compound with a broad spectrum of pharmacological properties.

The molecular structure of 3,4-dimethylcinnamic acid consists of a phenyl ring substituted with a propenoic acid (cinnamic acid) moiety at one end and two methyl groups at the ortho positions relative to this moiety. This structural configuration imparts unique electronic and steric properties to the molecule, influencing its reactivity and interaction with biological targets. The presence of the aromatic ring enhances its solubility in organic solvents while allowing for hydrogen bonding interactions with polar biomolecules, making it a valuable intermediate in synthetic chemistry.

In recent years, 3,4-dimethylcinnamic acid has been extensively investigated for its potential therapeutic applications. One of the most compelling areas of research has been its role as an antioxidant and anti-inflammatory agent. Studies have demonstrated that this compound can scavenge reactive oxygen species (ROS) and inhibit the activity of pro-inflammatory enzymes such as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX). These properties make it a promising candidate for developing treatments for oxidative stress-related diseases, including neurodegenerative disorders like Alzheimer's disease and Parkinson's disease.

Furthermore, 3,4-dimethylcinnamic acid has shown promise in cancer research. Preclinical studies have indicated that it can induce apoptosis in various cancer cell lines by modulating mitochondrial function and inhibiting survival signaling pathways. Specifically, it has been observed to downregulate the expression of anti-apoptotic proteins such as Bcl-2 while upregulating pro-apoptotic proteins like Bax. Additionally, its ability to inhibit tyrosine kinases has led to investigations into its potential as an anti-cancer therapeutic agent.

The compound's structural similarity to ferulic acid, another well-known phytochemical with multiple health benefits, has also sparked interest in 3,4-dimethylcinnamic acid as a nutraceutical ingredient. Ferulic acid is widely used in cosmetic formulations due to its antioxidant properties and ability to enhance skin health. By comparing the pharmacokinetic profiles and biological activities of both compounds, researchers aim to identify which one may offer superior benefits for human health applications.

Recent advancements in synthetic methodologies have enabled more efficient production of 3,4-dimethylcinnamic acid, making it more accessible for industrial applications. For instance, biocatalytic approaches using engineered microorganisms have been explored as sustainable alternatives to traditional chemical synthesis. These methods not only reduce environmental impact but also improve yield and purity, ensuring that pharmaceutical-grade material can be produced reliably.

The role of 3,4-dimethylcinnamic acid in drug development extends beyond its direct pharmacological effects. It serves as a valuable scaffold for designing novel molecules with enhanced efficacy and reduced side effects. By modifying its structure through chemical or enzymatic means, researchers can fine-tune its biological activity to target specific diseases more effectively. This flexibility makes it an attractive building block for medicinal chemists working on next-generation therapeutics.

In conclusion,3,4-dimethylcinnamic acid (CAS No: 60521-25-7) is a multifaceted compound with significant potential in pharmaceutical research and development. Its structural features enable diverse biological interactions, making it useful as an antioxidant, anti-inflammatory agent, and anti-cancer therapeutic. Ongoing studies continue to uncover new applications for this compound, reinforcing its importance in modern medicine. As synthetic techniques evolve and our understanding of its mechanisms improves,3,4-dimethylcinnamic acid is poised to play an increasingly vital role in addressing global health challenges.

• 3029-79-6(3-Methylcinnamic Acid)
• 621-82-9(Cinnamic acid)
• 16323-43-6(1,4-Benzenediacrylic Acid)
• 1552-94-9(Cinnamylideneacetic acid)
• 95883-10-6(3-(2,5-Dimethylphenyl)-2-propenoic Acid)
• 13026-23-8(4-Phenylcinnamic Acid)
• 140-10-3(trans-Cinnamic acid)
• 16089-48-8(Potassium cinnamate)
• 1866-39-3(4-Methylcinnamic acid)
• 2373-76-4(2-Methylcinnamic Acid)